Home Rethink OA Program For Clinicians Blog News About Contact My Library
Rethink OA ยท Value-Based Care

What could Rethink OA save your organization?

Savings estimates are modeled from our randomized clinical trial (npj Digital Medicine, 2024) and published health-economics literature. Adjust the inputs to match your population.

Your population

Tell us about the knee OA patients you manage.

$
5%

Baseline annual spend per patient

Typical non-surgical knee OA spend. Pre-filled from published cost data โ€” edit to match your claims.

$
$
$
Adjust savings assumptions (pre-set to our Base Case)โ–พ
25%
15%
15%
5%
$30
Estimated net annual savings
$3.4M
across 20,000 patients ยท after program costs
$170
net savings per patient / yr
2.8ร—
return on every program dollar
$170K
net savings per 1,000 patients

Where the savings come from (per patient / yr)

Surgery deferral
$68
Specialist visits
$60
Injections
$50
Activity & activation
$30
Imaging
$23
Gross savings $230  โˆ’  program cost $60= $170 net
Break-even: one deferred knee replacement covers the program for 450 patients โ€” just 2.2 deferred surgeries per 1,000 enrolled pays for everything.

Clinical outcomes are from a randomized controlled trial of Rethink OA (Boswell MA, et al. npj Digital Medicine 2024;7:285; NCT05698368). Cost assumptions draw on published health-economics literature including Losina 2015, Hibbard 2013, Sari 2019, and Wilson 2021 โ€” tap any โ“˜ for the specific source. In the trial, injection-use reduction was significant vs. an education control; surgery avoidance was not directly measured (the trial demonstrated reduced perceived need for surgery). Figures are illustrative estimates, not guaranteed savings; actual results depend on your population and implementation.